News
Media
All VideosMedical World NewsPodcastsWeekly RecapCure ConnectionsInsightsSpecial ReportNeurologyLive Peer ExchangeMedcastPeers & PerspectivesRoundtable Discussions
Conferences
Conference CoverageConference Listing
CME/CE
More
Partners
Publications
NeurologyLiveBridging the GapsInternational Journal of MS Care
Resources
Expert AuthorsFDA NewsFeaturesFellows' CornerFuture Leaders in NeurologyGiants of Multiple SclerosisInteractive ToolsJob BoardLive EventsNeurology ResourcesSponsoredVirtual Events

Subscribe

  • News
  • Media
  • Conferences
  • CME/CE
  • Partners
  • Publications
  • Resources
  • Subscribe
  • Dementia and Alzheimer Disease
  • Epilepsy
  • Genetic Disorders
  • Headache and Migraine
    • Migraine
  • MS and Demyelinating Disorders
    • NMOSD
    • Multiple Sclerosis
    • MS Advanced Practice Providers
  • Movement Disorders
    • Parkinson Disease
  • Neuromuscular
    • Chronic Inflammatory Demyelinating Polyneuropathy
    • Muscular Dystrophy
    • Ataxia
  • Rare Diseases
  • Sleep Disorders
    • Narcolepsy
    • Insomnia
  • Stroke
Spotlight -
Expert Authors|
FDA News|
ECTRIMS 2025|
MDS 2025
Advertisement

ACTRIMS 2020: Post-Conference Perspectives

EP. 1: ACTRIMS 2020 News Network: CLARITY Study on Relapsing Multiple Sclerosis

March 14th 2020

EP. 2: ACTRIMS 2020 News Network: Updated Data From the CLARITY Study

March 14th 2020

EP. 3: ACTRIMS 2020 News Network: EXPAND Study on Relapsing MS

March 14th 2020

EP. 4: ACTRIMS 2020 News Network: Effect of Disease Duration in the EXPAND Study

March 14th 2020

EP. 5: ACTRIMS 2020 News Network: OPERA I/II Trials on Relapsing MS

March 14th 2020

EP. 6: ACTRIMS 2020 News Network: 6-Year Data With Ocrelizumab

March 14th 2020

EP. 7: ACTRIMS 2020 News Network: APLIOS Bioequivalence Study on Relapsing MS

March 14th 2020

EP. 8: ACTRIMS 2020 News Network: B-Cell Depletion in the Phase 2 APLIOS Study

March 14th 2020

EP. 9: ACTRIMS 2020 News Network: Updated Recommendations for Standardized MRI Protocol in MS

March 14th 2020

EP. 10: ACTRIMS 2020 News Network: Standardized MRI Protocol for MS

March 14th 2020

EP. 11: ACTRIMS 2020 News Network: An Overview of Other Exciting Data

March 14th 2020

EP. 12: Immunosuppressive DMTs Associated With Longer COVID-19 Hospitalization in Patients With Multiple Sclerosis

ByAbby Reinhard
February 24th 2022

Investigators caution health care providers to consider specific risks of severe COVID-19 infection before initiating this therapy.

Advertisement
Advertisement

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

1

Parkinson Agent Tavapadon Shows Continued Efficacy, Safety in Phase 3 TEMPO-4 Trial

2

RWJBarnabas and Rutgers Health Researchers Pursue Advanced Neurostimulation Technology to Treat Epileptic Seizures

3

NeurologyLive® Brain Games: October 19, 2025

4

Refining Neonatal Continuous EEG Guidelines Through Evidence and Family Collaboration: Adam Numis, MD

5

Elecsys pTau181 Test Cleared, Tividenofusp Alfa PDUFA Pushed Back, Phase 4 LOTUS Study Highlights Real-World Benefit of Trofinetide

  • About Us
  • Advisory Board
  • Editorial
  • Contact Us
  • Advertise
  • Contact MJH LS
  • Do Not Sell My Information
  • Terms and Conditions
  • Privacy
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

  • Contagion Live
  • CGT Live
  • Neurology Live
  • HCP Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
HCP Live
Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us